 Radiation therapy localized prostate cancer Justification long-term follow-up series survival patterns years radiotherapy patients clinical stage carcinoma prostate age-matched peer group patients clinical stage disease nodular disease involvement lateral lobe survival years age-matched group California men spite fact lymph node status true incidence capsular penetration unknown patients histopathologic grade acid phosphatase prostate-specific antigen values patients intermediate low Gleason scores normal acid phosphatase low prostate-specific antigen values likely difference survival prostatic cancer age-matched peers conservative selection criteria patients advanced stages likelihood survival diminishes radiation treatment patients disease clinical examination prostate advanced radical prostatectomy cent cent chance survival